• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Discovery of potent and selective inhibitors of thymidylate synthase for opportunistic infections.发现用于机会性感染的胸苷酸合成酶的强效和选择性抑制剂。
ACS Med Chem Lett. 2013 Oct 4;4(12):1148-1151. doi: 10.1021/ml400208v.
2
First three-dimensional structure of Toxoplasma gondii thymidylate synthase-dihydrofolate reductase: insights for catalysis, interdomain interactions, and substrate channeling.刚地弓形虫胸苷酸合酶-二氢叶酸还原酶的首个三维结构:对催化、结构域间相互作用和底物通道的深入了解。
Biochemistry. 2013 Oct 15;52(41):7305-7317. doi: 10.1021/bi400576t. Epub 2013 Oct 3.
3
Selective peptide inhibitors of bifunctional thymidylate synthase-dihydrofolate reductase from Toxoplasma gondii provide insights into domain-domain communication and allosteric regulation.从刚地弓形虫中分离出二氢叶酸还原酶-胸苷酸合成酶双功能蛋白的选择性肽抑制剂为研究结构域间通讯和别构调节提供了线索。
Protein Sci. 2013 Sep;22(9):1161-73. doi: 10.1002/pro.2300. Epub 2013 Aug 1.
4
Virtual screening reveals allosteric inhibitors of the Toxoplasma gondii thymidylate synthase-dihydrofolate reductase.虚拟筛选揭示弓形虫胸苷酸合酶-二氢叶酸还原酶的别构抑制剂。
Bioorg Med Chem Lett. 2014 Feb 15;24(4):1232-5. doi: 10.1016/j.bmcl.2013.12.039. Epub 2013 Dec 31.
5
Structural Insight into Effective Inhibitors' Binding to Dihydrofolate Reductase Thymidylate Synthase.二氢叶酸还原酶胸苷酸合酶有效抑制剂结合的结构见解。
ACS Chem Biol. 2022 Jul 15;17(7):1691-1702. doi: 10.1021/acschembio.1c00627. Epub 2022 Jun 17.
6
Primary structure of the dihydrofolate reductase-thymidylate synthase gene from Toxoplasma gondii.来自刚地弓形虫的二氢叶酸还原酶-胸苷酸合成酶基因的一级结构
J Biol Chem. 1993 Mar 25;268(9):6269-80.
7
Heterologous expression and characterization of the bifunctional dihydrofolate reductase-thymidylate synthase enzyme of Toxoplasma gondii.刚地弓形虫双功能二氢叶酸还原酶-胸苷酸合成酶的异源表达及特性分析
Biochemistry. 1996 May 21;35(20):6366-74. doi: 10.1021/bi952923q.
8
Knocking down of the DHFR-TS gene in Toxoplasma gondii using siRNA and assessing the subsequences on toxoplasmosis in mice.利用 siRNA 敲低弓形虫 DHFR-TS 基因并评估其对小鼠弓形虫病的影响。
Acta Trop. 2020 Jul;207:105488. doi: 10.1016/j.actatropica.2020.105488. Epub 2020 Apr 8.
9
Mechanistic characterization of Toxoplasma gondii thymidylate synthase (TS-DHFR)-dihydrofolate reductase. Evidence for a TS intermediate and TS half-sites reactivity.刚地弓形虫胸苷酸合成酶(TS-DHFR)-二氢叶酸还原酶的机制表征。TS中间体和TS半位点反应性的证据。
J Biol Chem. 2002 Nov 8;277(45):43126-36. doi: 10.1074/jbc.M206523200. Epub 2002 Aug 20.
10
Characterization of dihydrofolate reductase of Pneumocystis carinii and Toxoplasma gondii.卡氏肺孢子虫和刚地弓形虫二氢叶酸还原酶的特性研究
Exp Parasitol. 1990 Jul;71(1):60-8. doi: 10.1016/0014-4894(90)90008-z.

引用本文的文献

1
Molecular Detection of Genetic Material of in Goat Blood Samples from Northern Thailand.泰国北部山羊血样中[具体物质]遗传物质的分子检测 。 (你原文中“of ”后面缺少具体内容)
Vet Sci. 2025 Jun 5;12(6):555. doi: 10.3390/vetsci12060555.
2
Discovery of potent anti-toxoplasmosis drugs from secondary metabolites in Citrus limon (lemon) leaves, supported in-silico study.从柠檬叶次生代谢产物中发现强效抗弓形虫病药物的计算机辅助研究。
Sci Rep. 2025 Jan 3;15(1):624. doi: 10.1038/s41598-024-82787-9.
3
Evaluation of A. DC. Leaves and Its Isolated Secondary Metabolites as Natural Anti-Toxoplasma and Anti-Cancer Agents Using In Vitro and In Silico Studies.利用体外和计算机模拟研究评估黄花蒿叶及其分离的次生代谢产物作为天然抗弓形虫和抗癌剂的作用
Metabolites. 2022 Dec 21;13(1):10. doi: 10.3390/metabo13010010.
4
Drug Repurposing Based on Protozoan Proteome: In Vitro Evaluation of In Silico Screened Compounds against .基于原生动物蛋白质组的药物重新利用:对计算机筛选出的化合物进行体外评估……(原文此处不完整)
Pharmaceutics. 2022 Aug 5;14(8):1634. doi: 10.3390/pharmaceutics14081634.
5
QSAR Modeling for Multi-Target Drug Discovery: Designing Simultaneous Inhibitors of Proteins in Diverse Pathogenic Parasites.用于多靶点药物发现的定量构效关系建模:设计针对多种致病寄生虫中蛋白质的同时抑制剂
Front Chem. 2021 Mar 10;9:634663. doi: 10.3389/fchem.2021.634663. eCollection 2021.
6
Pyrido-Fused Deazapurine Bases: Synthesis and Glycosylation of 4-Substituted 9-Pyrido[2',3':4,5]- and Pyrido[4',3':4,5]pyrrolo[2,3-]pyrimidines.吡啶并稠合脱氮嘌呤碱基:4-取代的9-吡啶并[2',3':4,5]-和吡啶并[4',3':4,5]吡咯并[2,3-]嘧啶的合成与糖基化
ACS Omega. 2020 Oct 2;5(40):26278-26286. doi: 10.1021/acsomega.0c04302. eCollection 2020 Oct 13.
7
In vitro therapeutic effect of venom on tachyzoites of .毒液对[某种生物]速殖子的体外治疗效果。 (原文中“venom on tachyzoites of.”后缺少具体生物名称)
J Parasit Dis. 2019 Sep;43(3):472-478. doi: 10.1007/s12639-019-01113-7. Epub 2019 Apr 20.
8
Systematic Identification of Thiosemicarbazides for Inhibition of Growth In Vitro.系统鉴定硫代卡巴肼类化合物对体外生长的抑制作用。
Molecules. 2019 Feb 10;24(3):614. doi: 10.3390/molecules24030614.
9
Molecular docking to Toxoplasma gondii thymidylate synthase-dihydrofolate reductase and efficacy of raltitrexed in infected mice.与刚地弓形虫胸苷酸合酶-二氢叶酸还原酶的分子对接及雷替曲塞在感染小鼠中的疗效
Parasitol Res. 2018 May;117(5):1465-1471. doi: 10.1007/s00436-018-5835-5. Epub 2018 Mar 17.
10
Understanding the molecular mechanism of substrate channeling and domain communication in protozoal bifunctional TS-DHFR.了解原生动物双功能TS-DHFR中底物通道化和结构域通讯的分子机制。
Protein Eng Des Sel. 2017 Mar 1;30(3):253-261. doi: 10.1093/protein/gzx004.

本文引用的文献

1
First three-dimensional structure of Toxoplasma gondii thymidylate synthase-dihydrofolate reductase: insights for catalysis, interdomain interactions, and substrate channeling.刚地弓形虫胸苷酸合酶-二氢叶酸还原酶的首个三维结构:对催化、结构域间相互作用和底物通道的深入了解。
Biochemistry. 2013 Oct 15;52(41):7305-7317. doi: 10.1021/bi400576t. Epub 2013 Oct 3.
2
HIV cure: knocking on the door.HIV 治愈:敲响大门。
Clin Pharmacol Ther. 2013 May;93(5):382-4. doi: 10.1038/clpt.2013.22.
3
Single agents with designed combination chemotherapy potential: synthesis and evaluation of substituted pyrimido[4,5-b]indoles as receptor tyrosine kinase and thymidylate synthase inhibitors and as antitumor agents.具有设计组合化疗潜力的单药:取代的嘧啶并[4,5-b]吲哚作为受体酪氨酸激酶和胸苷酸合成酶抑制剂及抗肿瘤剂的合成与评价。
J Med Chem. 2010 Feb 25;53(4):1563-78. doi: 10.1021/jm9011142.
4
Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.《HIV 感染成人及青少年机会性感染的预防与治疗指南:美国疾病控制与预防中心、国立卫生研究院及美国传染病学会 HIV 医学协会的建议》
MMWR Recomm Rep. 2009 Apr 10;58(RR-4):1-207; quiz CE1-4.
5
Ligand-free copper-catalyzed C-S coupling of aryl iodides and thiols.无配体铜催化的芳基碘化物与硫醇的C-S偶联反应
J Org Chem. 2008 Jul 18;73(14):5625-8. doi: 10.1021/jo800491k. Epub 2008 Jun 21.
6
Sequence-based identification of specific drug target regions in the thymidylate synthase enzyme family.基于序列的胸苷酸合成酶酶家族中特定药物靶标区域的鉴定。
ChemMedChem. 2008 Mar;3(3):392-401. doi: 10.1002/cmdc.200700215.
7
Targeting purine and pyrimidine metabolism in human apicomplexan parasites.针对人类顶复门寄生虫中的嘌呤和嘧啶代谢
Curr Drug Targets. 2007 Jan;8(1):31-47. doi: 10.2174/138945007779315524.
8
Differential drug binding by the highly conserved Plasmodium falciparum thymidylate synthase.恶性疟原虫胸苷酸合成酶高度保守区域的药物差异性结合
Mol Biochem Parasitol. 2005 Sep;143(1):121-4. doi: 10.1016/j.molbiopara.2005.02.016.
9
Toxoplasmosis.弓形虫病
Lancet. 2004 Jun 12;363(9425):1965-76. doi: 10.1016/S0140-6736(04)16412-X.
10
The molecular basis of sulfonamide resistance in Toxoplasma gondii and implications for the clinical management of toxoplasmosis.弓形虫磺胺类药物耐药性的分子基础及其对弓形虫病临床管理的意义。
J Infect Dis. 2002 Jun 1;185(11):1637-43. doi: 10.1086/340577. Epub 2002 May 17.

发现用于机会性感染的胸苷酸合成酶的强效和选择性抑制剂。

Discovery of potent and selective inhibitors of thymidylate synthase for opportunistic infections.

作者信息

Zaware Nilesh, Sharma Hitesh, Yang Jie, Devambatla Ravi Kumar Vyas, Queener Sherry F, Anderson Karen S, Gangjee Aleem

机构信息

Division of Medicinal Chemistry, Graduate School of Pharmaceutical Sciences, Duquesne University, 600 Forbes Avenue, Pittsburgh, PA 15282, United States.

Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06511, United States.

出版信息

ACS Med Chem Lett. 2013 Oct 4;4(12):1148-1151. doi: 10.1021/ml400208v.

DOI:10.1021/ml400208v
PMID:24470841
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3901304/
Abstract

Infection by the parasite (tg) can lead to toxoplasmosis in immunocompromised patients such as organ transplant, cancer and HIV/AIDS patients. The bifunctional thymidylate synthase-dihydrofolate reductase (TS-DHFR) enzyme is crucial for nucleotide synthesis in , and represents a potential target to combat infection. While species selectivity with drugs has been attained for DHFR, TS is much more conserved across species and specificity is significantly more challenging. We discovered novel substituted-9-pyrimido[4,5-]indoles - with single-digit nanomolar K for tgTS, two of which, and , are 28- and 122-fold selective over human TS (hTS). The synthesis of these compounds, and their structures in complex with tgTS-DHFR are presented along with binding measurements and cell culture data. These results show, for the very first time, that in spite of the high degree of conservation of active site residues between hTS and the parasite TS, specificity has been accomplished via novel structures and provides a new target (TS) for selective drug development against parasitic infections.

摘要

寄生虫(tg)感染可导致免疫功能低下患者(如器官移植患者、癌症患者和艾滋病毒/艾滋病患者)患弓形虫病。双功能胸苷酸合成酶-二氢叶酸还原酶(TS-DHFR)酶对(寄生虫名称未明确,原文此处有误)的核苷酸合成至关重要,是对抗(寄生虫名称未明确,原文此处有误)感染的潜在靶点。虽然针对二氢叶酸还原酶已实现药物的物种选择性,但胸苷酸合成酶在物种间更为保守,实现特异性更具挑战性。我们发现了新型取代的9-嘧啶并[4,5-]吲哚——对tgTS的K值为个位数纳摩尔,其中两种化合物(化合物名称未明确,原文此处有误)对人TS(hTS)的选择性分别为28倍和122倍。本文介绍了这些化合物的合成方法、它们与tgTS-DHFR复合物的结构,以及结合测量结果和细胞培养数据。这些结果首次表明,尽管hTS和寄生虫TS的活性位点残基高度保守,但已通过新型结构实现了特异性,并为开发针对寄生虫感染的选择性药物提供了新靶点(TS)。